Oropharyngeal Cancer - Pipeline Review, H2 2012 New Report
Oropharyngeal Cancer - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Oropharyngeal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Oropharyngeal Cancer. Oropharyngeal Cancer - Pipeline Review, Half Year is built using data and information sourced databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and...
View full press release